Specialty Care Tied to Reduced Mortality in New-Onset A-Fib

This article originally appeared here.
Share this content:
Specialty Care Tied to Reduced Mortality in New-Onset A-Fib
Specialty Care Tied to Reduced Mortality in New-Onset A-Fib

MONDAY, Dec. 4, 2017 (HealthDay News) -- Cardiologist care is associated with a lower rate of death in patients with new-onset atrial fibrillation (AF), according to a study published in the December issue of the Canadian Journal of Cardiology.

Sheldon M. Singh, M.D., from the University of Toronto, and colleagues assessed the association between cardiologist care and clinical outcomes among patients (aged 20 to 80 years) presenting to an emergency department with new-onset AF between 2010 and 2012. Administrative databases were used to match patients who saw and did not see a cardiologist within one year of the initial diagnosis and allowed for assessment of clinical end points.

The researchers found that cardiologist care was associated with a lower one-year rate of death (hazard ratio, 0.68). This decreased rate of death existed despite an increased rate of hospitalizations for AF, stroke syndromes, bleeding, and heart failure associated with cardiologist care.

"Further study to obtain a greater understanding of the processes of care associated with the observed survival improvement is warranted," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »